Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 5 studies | 24% ± 9% | |
| epithelial cell | 5 studies | 24% ± 5% | |
| astrocyte | 5 studies | 31% ± 11% | |
| oligodendrocyte | 5 studies | 25% ± 7% | |
| GABAergic neuron | 4 studies | 43% ± 13% | |
| oligodendrocyte precursor cell | 4 studies | 30% ± 7% | |
| microglial cell | 3 studies | 19% ± 1% | |
| glutamatergic neuron | 3 studies | 60% ± 3% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 5 studies | 40% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 1196.64 | 1445 / 1445 | 100% | 5.78 | 183 / 183 |
| lung | 100% | 1230.00 | 576 / 578 | 100% | 5.41 | 1153 / 1155 |
| breast | 100% | 1355.70 | 459 / 459 | 99% | 6.75 | 1112 / 1118 |
| prostate | 100% | 1309.58 | 245 / 245 | 99% | 6.31 | 496 / 502 |
| thymus | 100% | 1721.85 | 653 / 653 | 99% | 5.62 | 597 / 605 |
| kidney | 100% | 1069.96 | 89 / 89 | 99% | 6.09 | 889 / 901 |
| pancreas | 100% | 828.08 | 327 / 328 | 99% | 4.79 | 176 / 178 |
| bladder | 100% | 1257.52 | 21 / 21 | 98% | 5.08 | 496 / 504 |
| intestine | 100% | 1462.38 | 966 / 966 | 98% | 5.36 | 518 / 527 |
| adrenal gland | 100% | 1120.19 | 258 / 258 | 98% | 5.01 | 226 / 230 |
| ovary | 100% | 1850.02 | 180 / 180 | 98% | 3.62 | 422 / 430 |
| uterus | 100% | 1613.48 | 170 / 170 | 98% | 5.32 | 450 / 459 |
| stomach | 100% | 2216.13 | 359 / 359 | 98% | 5.30 | 280 / 286 |
| brain | 97% | 807.15 | 2570 / 2642 | 100% | 6.56 | 705 / 705 |
| skin | 100% | 1340.02 | 1809 / 1809 | 96% | 7.05 | 451 / 472 |
| liver | 100% | 758.86 | 226 / 226 | 94% | 3.51 | 382 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 4.67 | 29 / 29 |
| spleen | 100% | 1201.57 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 5.22 | 45 / 45 |
| adipose | 100% | 1121.53 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1054.43 | 1333 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 99% | 597.05 | 791 / 803 | 0% | 0 | 0 / 0 |
| heart | 95% | 733.45 | 815 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 78% | 2.80 | 62 / 80 |
| peripheral blood | 54% | 768.39 | 504 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0098901 | Biological process | regulation of cardiac muscle cell action potential |
| GO_0002027 | Biological process | regulation of heart rate |
| GO_0005886 | Cellular component | plasma membrane |
| Gene name | TMEM161B |
| Protein name | Transmembrane protein 161B (cDNA FLJ51081) Transmembrane protein 161B (cDNA FLJ59764) Transmembrane protein 161B |
| Synonyms | UNQ679/PRO1313 |
| Description | FUNCTION: Essential for maintaining normal cardiac rhythm in the developing heart and for neonatal survival (By similarity). Inhibits potassium and calcium currents in the cardiomyocytes, this assists in timely action potential repolarization and thereby maintains normal cardiac rhythm (By similarity). . |
| Accessions | ENST00000512429.5 ENST00000507872.1 ENST00000510089.5 [Q8NDZ6-3] B7Z6A5 ENST00000514135.5 ENST00000511218.5 ENST00000509387.5 ENST00000511087.5 B7Z6T3 D6RAR3 Q8NDZ6 ENST00000296595.11 [Q8NDZ6-1] ENST00000506536.5 E9PFW6 D6RBE8 D6RAK4 E9PCX5 |
